- Filed
- Mar 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 21, 2025 | 3M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 538.01K sh |
| Capex | FY 2024 · Dec 31, 2023 | $0 |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$9.56M |
| Short Term Investments | FY 2024 · Dec 31, 2023 | $0 |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $2.45M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $1.63M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $7.6M |
| Current Assets | FY 2024 · Dec 31, 2023 | $4.74M |
| Total Assets | FY 2024 · Dec 31, 2023 | $13.71M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$24.25 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$24.25 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $4.66M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $4.03M |
| Net Income | FY 2024 · Dec 31, 2023 | −$12.51M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$12.59M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $11.41M |